Видео ютуба по тегу Speaker: Axel Merseburger

High risk prostate cancer and mHSPC | With Axel Merseburger
High risk prostate cancer and mHSPC | With Axel Merseburger
Axel Merseburger, ESMO 2019 - Advances in metastatic hormone-sensitive prostate cancer
Axel Merseburger, ESMO 2019 - Advances in metastatic hormone-sensitive prostate cancer
Axel Merseburger, ASCO20: Clinical Updates in Urothelial Carcinoma and Renal Cell Carcinoma
Axel Merseburger, ASCO20: Clinical Updates in Urothelial Carcinoma and Renal Cell Carcinoma
Clinical insights into prostate cancer trial data | Axel Merseburger
Clinical insights into prostate cancer trial data | Axel Merseburger
Binaural Audio - Trois Píéces by César Franck, ImmersAV Loudspeaker Version
Binaural Audio - Trois Píéces by César Franck, ImmersAV Loudspeaker Version
How can social media be used to stay up to date in uro-oncology?
How can social media be used to stay up to date in uro-oncology?
Discovering novel biomarkers in prostate cancer
Discovering novel biomarkers in prostate cancer
What is the best second-line treatment of advanced renal cell carcinoma (RCC)?
What is the best second-line treatment of advanced renal cell carcinoma (RCC)?
Does it makes a difference which androgen deprivation therapy you use?
Does it makes a difference which androgen deprivation therapy you use?
Binaural-Loudspeaker Version, 5-26-2104 Outdoor DEXTER Session
Binaural-Loudspeaker Version, 5-26-2104 Outdoor DEXTER Session
Predicting Survival of Men with Prostate Cancer after RP
Predicting Survival of Men with Prostate Cancer after RP
The evolving treatment landscape of mHSPC and mCRPC
The evolving treatment landscape of mHSPC and mCRPC
Vibraphonics
Vibraphonics
PRESIDE: investigating continued treatment with enzalutamide in PC following disease progression
PRESIDE: investigating continued treatment with enzalutamide in PC following disease progression
TITAN: update on the data and where next for patients with hormone sensitive PC
TITAN: update on the data and where next for patients with hormone sensitive PC
Advanced prostate cancer treatment – if, when and what?
Advanced prostate cancer treatment – if, when and what?
The impact of COVID-19 on the care of patients with metastatic GU cancers
The impact of COVID-19 on the care of patients with metastatic GU cancers